RAJESH KUKUNOOR, M.D.
CURRICULUM VITAE
Ironwood Cancer & Research Centers a division of
Ironwood Physicians, PC
EDUCATION
Nizam College Hyderabad, India, B.Sc. (I) Genetics
Osmania Medical College, Hyderabad, India. M.B; B.S (M.D)
POST-GRADUATE TRAINING
Board Certified
Hematology and Medical Oncology
American Board of Internal Medicine
Fellowship
Hematology and Medical Oncology
Cleveland clinic Foundation, Cleveland, OH.
Residency
Internal Medicine
Wayne State University, Detroit, Michigan.
Family Practice (PGY-1, 2)
North Oakland Medical Centers, Pontiac, Michigan
WORK EXPERIENCE
Hematologist/Oncologist , Ironwood Physicians, PC, Phoenix AZ 85028
Hematologist/Oncologist , Southwest Hematology Oncology, Phoenix AZ 85028
Oncology Hospitalist, Heartland Regional Medical Center, St.Joseph, Missouri
CURRENT LICENCE
State of Arizona
RESEARCH AND ABSTRACTS

Basic research: Studied the effects of Combretastatin A-4 on CLL cells in
vitro as part of my research project during residency.

Proximal Myopathy in a healthy 32-year-old female: an unusual presentation
of Grave’s disease. Rajesh Kukunoor. Judith Andersen. American College
of Physicians. Michigan Chapter Annual Scientific Meeting, 1998.

Disseminated Nocardiosis presenting as right-sided weakness in a patient on
chronic steroid therapy. Syed Karim. Rajesh Kukunoor. American College
of Physicians. Michigan Chapter Annual Scientific Meeting, 1998.

Broncholithiasis: A rare cause of hemoptysis. Rajesh Kukunoor. American
College of Physicians. Michigan Chapter Annual Scientific Meeting, 1999.

Brain Metastasis: A rare presentation of Pancreatic carcinoma- A case report
and review of literature. Aparna Mahakala, Rajesh Kukunoor. American
College of Physicians. Michigan Chapter Annual Scientific Meeting, 1999.

Cardiac tamponade in a hypothyroid patient presenting with severe
systemic hypertension. Jyothy Puthumana, Naveed Akthar, Rajesh
Kukunoor. American College of Physicians. Michigan Chapter Annual
Scientific Meeting, 1999.

T-cell subsets as a predictor of the effects of IL-2 maintenance therapy (MT)
on progression free survival (PFS) and overall survival (OS) in multiple
myeloma (MM). Kukunoor R, O’brien E, Elson P, Platt L, Snyder J and
Hussein M. American Society of Hematology 2003. Abst #5241.

Rituximab Therapy For Chronic Relapsing Thrombotic Thrombocytopenic
Purpura. Kukunoor R, Koo A, Mekhail T. Journal of Clinical Apheresis 2004,
19(1):35.
ORAL PRESENTATIONS

Rituximab Therapy For Chronic Relapsing Thrombotic Thrombocytopenic
Purpura. Kukunoor R, World Apheresis Association 10 th Congress,
American Society for Apheresis 25 th Annual Meeting, May 8 th , 2004. Miami,
FL.
PUBLICATIONS

Targeted Therapy for Lung Cancer. Kukunoor R, Shah J and Mekhail T.
Current Oncology Reports 2003, 5:326-333.

Clinical Significance of Cytogenetics in Multiple Myeloma and Chronic
Lymphocytic leukemia. Shah J, Kukunoor R , Theil C, Kaylacio M.
Laboratory Medicine 2004, 35(11):685-692.
MEMBERSHIPS
American Society of Clinical Oncology
American society of Hematology
BOOK CHAPTERS
Tumor Lysis Syndrome, Disseminated intravascular coagulation and Other noninfectious complications of Leukemia and Lymphoma. Rajesh Kukunoor and
Mikkael Sekeres. Clinical Malignant Hematology Chapter 107; 1159-1171.
SPEAKING ENGAGEMENTS
Extensive experience in community oncology speaking, currently speak for six
Pharmaceutical companies nationwide